foxo4-dri senolytic peptide human trial foxo4 dri Molecular modelling of the FOXO4-TP53 interaction to design peptides for the elimination of senescent cancer cells The disordered p53 transactivation domain – Peptide inhibitors targeting FOXO4-p53 interactions
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12



























